Understanding how body composition, hormones, and exercise affect men

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to explore the causes of normal-weight obesity in men by examining hormone profiles and related mechanisms. It will assess the effectiveness of different exercise modalities, including resistance and aerobic training, in improving body composition and cardiometabolic health. The study will involve biological males with specific BMI and body fat criteria who are willing to participate in an exercise regimen.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Biological male
* BMI 18.5 - 24.9 kg/m2 or \>/= 30 kg/m2
* Body fat \<20% or \>/= 25%
* Ability and willingness to engage in an exercise training regimen

Exclusion Criteria:

* Presence of a chronic health condition, or regular use of associate prescribed medications, that would substantially impact study variables
* Excessive alcohol use or use of tobacco products, vape products, or illicit drugs
* Presence of an electrical implant, such as a pacemaker

Where it's running

• Oklahoma State University
  Stillwater, Oklahoma, United States Recruiting

Study contacts

• Principal investigator: Sam Emerson, PhD — Oklahoma State University
• Study coordinator: Sam Emerson, PhD
• Email: sam.emerson@okstate.edu
• Phone: 4057442303

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Impact of body composition on vascular health in healthy-weight females

  This study is testing how the balance of fat and muscle in healthy-weight women affects their blood vessel health after eating a high-fat meal or experiencing stress.

  Recruiting Ball State University · Muncie, Indiana · NCT06818500

• How GLP-1 in the brain responds to sugar in people of different weights

  This study tests whether the gut hormone GLP-1 changes how the brain reacts to sugar in people with healthy weight and those with obesity.

  Recruiting University of Copenhagen · Copenhagen · NCT07854886

• Investigating the impact of a GLP-1 medication on brain insulin response

  This study is testing if a medication called semaglutide can change how the brain responds to insulin in people of different weights to see if it helps with thinking and eating habits.

  Recruiting University Hospital Tuebingen · Tübingen · NCT06487832

• Long-term Iron Absorption in Women with Overweight/Obesity vs Normal Weight

  This study tests long-term iron absorption and loss in women aged 40–50, comparing those who are overweight/obese with those of normal weight.

  Recruiting Mahidol University · Nakhon Pathom · NCT07855939

• XTL6001 injection in healthy adults and adults with overweight or obesity

  This trial tests single and multiple doses of XTL6001 injection to see if it is safe and to measure how the drug behaves in healthy adults and adults with overweight or obesity.

  Recruiting Phase 1 Shanghai Xitaili Biomedicine Technology co., Ltd. · Beijing, Beijing Municipality · NCT07205432

• IBI362 for weight loss in Chinese adolescents with obesity or overweight

  This research will see if different doses of IBI362 help Chinese adolescents aged 12–17 with obesity or overweight and weight-related health problems lose weight after diet and exercise did not produce at least a 5 kg reduction.

  Recruiting Phase 3 Innovent Biologics (Suzhou) Co. Ltd. · Hangzhou, Zhejiang · NCT07255209

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.